Loading...
 

The Price of Admission: Licensee Challenges to Patents After Medimmune v. Genentech

Name
The Price of Admission: Licensee Challenges to Patents After Medimmune v. Genentech
Cite
51-JUN BBJ 10
Year
2007
Bluebook cite
Erik Belt and Keith Toms, The Price of Admission: Licensee Challenges to Patents After Medimmune v. Genentech, 51 Boston Bar Journal 10 (May/June 2007)
Author
Erik Belt and Keith Toms
URL
Item Type
article
Summary
Analysis of the Medimmune decision. Authors conclude that Medimmune does not eliminate the consequences of challenging a licensing agreement.

Excerpts and Summaries

Created
Saturday 15 of November, 2008 18:18:07 GMT
by Unknown
LastModif
Saturday 15 of November, 2008 18:18:07 GMT
by Unknown


Portions © 2006-2019 by Michael Risch, Some Rights Reserved | Copyright Notice| Legal Disclaimer